1. 氨磺必利治疗精神分裂症临床应用专家意见.
- Author
-
梁英, 刘登堂２, 司天梅, 李毅, 张聪沛, 李涛, 许秀峰, 高成阁, 王智民, 况利, 谭庆荣, 陈致宇, 施慎逊, 刘铁榜, 杨甫德, 王高华, 赵靖平, 江开达, and 于欣
- Abstract
Amisulpride, a kind of the second generation antipsychotics, was marketed in China in 2010. A series of clinical research and experience before and after listed, especially the data based on Chinese population, provided evidence for the generalization and application of amisulpride. In order to optimize the clinical application of amisulpride, and improve the prognosis of patients, Expert Advice on the Practical Use of Amisulpride in the Treatment of Schizophrenia is presented here. This advice is based on the recent evidence and clinical experience, for guiding the clinical medication of amisulpride. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF